Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers.

Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers.

Item
http://www.wikidata.org/entity/Q33389284
Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiationEfficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II studyThe Eltrombopag antitumor effect on hepatocellular carcinoma.Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia.Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development.Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals.Eltrombopag: a review of its use in patients with severe aplastic anaemia.Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.
P2860

Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers.

Item
http://www.wikidata.org/entity/Q33389284
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@ast
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@en
type
label
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@ast
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@en
prefLabel
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@ast
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Clinical pharmacokinetics, pla ...... e daily in healthy volunteers.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698